Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2000 2
2001 2
2002 1
2003 3
2004 1
2005 1
2006 1
2007 1
2008 2
2009 1
2010 1
2011 2
2013 1
2014 1
2015 1
2016 1
2017 2
2018 1
2019 1
2020 4
2021 4
2022 2
2023 4
2024 2
2025 5
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.
Gil JV, Sargas C, Ayala R, Gutierrez NC, Pérez-Simón JA, Gómez-Casares MT, Larrayoz MJ, Prados de la Torre E, Cano-Ferri I, Navarro I, Gil C, Bernal Del Castillo T, Rodríguez-Arbolí E, Pérez Santaolalla E, Colmenares R, Tormo M, Bergua Burgues JM, Amigo ML, Rodríguez-Medina C, Serrano J, Oliva A, Alonso-Domínguez JM, Noriega V, Algarra JL, Olave MT, García Perez MJ, Couto MDC, Almela-Gallego A, García-Fortes M, Madrigal-Toscano DD, Hermosín L, Colorado M, García-Boyero R, Ibañez-Alis F, Solé-Rodríguez M, Martinez Chamorro C, Mateos MC, García Garay MDC, Solana-Altabella A, Martín-Herreros B, Martínez-López J, Chillon MC, Soria E, Bilbao-Sieyro C, Calasanz MJJ, Sánchez-García J, Barragan E, Montesinos P. Gil JV, et al. Blood. 2026 Jun 8:blood.2026033576. doi: 10.1182/blood.2026033576. Online ahead of print. Blood. 2026. PMID: 42258402 Free article.
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study.
Gil JV, Sargas C, Ayala R, Gutiérrez NC, Pérez-Simón JA, Gómez-Casares MT, Larrayoz MJ, La Torre EP, Cano-Ferri I, Navarro I, Gil C, Bernal T, Rodríguez-Arbolí E, Pérez-Santaolalla E, Colmenares R, Tormo M, Bergua J, Amigo ML, Rodríguez-Medina C, Serrano J, Oliva AY, Alonso-Domínguez JM, Noriega V, Algarra L, Olave M, García-Pérez MJ, Couto C, Almela Á, García-Fortes M, Madrigal MD, Hermosín ML, Colorado M, García-Boyero R, Ibáñez F, Solé M, Martínez-Chamorro C, Mateos MDC, García-Garay MDC, Solana-Altabella A, Martín-Herreros B, Martínez-López J, Chillón MDC, Soria E, Bilbao C, Calasanz MJ, Sánchez-García J, Barragán E, Montesinos P. Gil JV, et al. Haematologica. 2026 Jul 16. doi: 10.3324/haematol.2026.301025. Online ahead of print. Haematologica. 2026. PMID: 42459121 Free article.
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.
Solana-Altabella A, Iniesta-Navalón C, Chovi-Trull M, Rodriguez-Veiga R, Lopez-Nogueroles M, Martínez-Cuadrón D, Gil-Candel M, Torres-Miñana L, Acuña-Cruz E, Cano-Ferri I, Boluda B, Navarro-Vicente I, Lloret-Madrid P, Barragán E, Gil JV, Rodenas-Rovira M, Megías-Vericat JE, Labrador J, Peris-Ribera JE, Poveda-Andrés JL, Montesinos P. Solana-Altabella A, et al. Among authors: gil jv. Eur J Clin Pharmacol. 2025 Nov;81(11):1699-1709. doi: 10.1007/s00228-025-03909-4. Epub 2025 Aug 30. Eur J Clin Pharmacol. 2025. PMID: 40884550 Free PMC article. Clinical Trial.
Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study.
Barragán E, Gil JV, Ayala R, Chillón C, Soria E, Bilbao C, Larráyoz MJ, Prados de la Torre E, Solana A, Martínez-Cuadrón D, Rodríguez-Veiga R, Rodríguez-Arbolí E, Tormo M, Martínez P, Lavilla E, García-Garay MC, Arce O, Bergua J, Serrano J, Botella C, Lacalzada C, Almela-Gallego A, Lopez-Lorenzo JL, Valero M, Ibañez F, Foncillas MÁ, Rodriguez-Medina C, Olave M, Gómez-Correcha KG, Calderón MT, Bernal T, Labrador J, Oliva A, Madrigal MD, Hermosín L, Amador L, García-Belmonte D, Herrera P, Vives S, Perez-Encinas M, Algarra L, Casado S, Martínez-Chamorro C, Polo M, Balerdi A, Roldán A, Couto C, Pereiro M, Vanegas R, Llop M, Sargas C, Cionfrini A, Mendizábal Y, Sánchez J, Calasanz MJ, Gómez-Casares MT, Pérez-Simón JA, García-Sanz R, Martínez-López J, Montesinos P; PETHEMA group. Barragán E, et al. Among authors: gil jv. Blood Neoplasia. 2026 Apr 25;3(3):100238. doi: 10.1016/j.bneo.2026.100238. eCollection 2026 Aug. Blood Neoplasia. 2026. PMID: 42294112 Free PMC article.
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á, Mora E, Avetisyan G, Furió S, De la Puerta R, Gil JV, Liquori A, Villamón E, García-Hernández C, Santiago M, García-Ruiz C, Llop M, Ferrer-Lores B, Barragán E, García-Palomares S, Mayordomo E, Luna I, Vicente A, Cordón L, Senent L, Álvarez-Larrán A, Cervera J, De la Rubia J, Hernández-Boluda JC, Such E. Díaz-González Á, et al. Among authors: gil jv. Cancers (Basel). 2023 Jun 2;15(11):3039. doi: 10.3390/cancers15113039. Cancers (Basel). 2023. PMID: 37297002 Free PMC article.
49 results